Histamine H4 receptors regulate ACTH release in AtT-20 cells

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 336-338

  Meng, Jia ^a   Ma, Xue ^a   Li, Mingkai ^a   Jia, Min ^a   Luo, Xiaoxing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ACTH; AtT 20 cell; Histamine H4 receptor; JNJ 7777120

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; ALPHA METHYLHISTAMINE; CORTICOTROPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CORTICOTROPIN RELEASE; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOLOGICAL BLOCKING; PLASMACYTOMA; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL LINE; HISTAMINE ANTAGONISTS; INDOLES; METHYLHISTAMINES; MICE; PIPERAZINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44149106334     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.03.019     Document Type: Article

References (22)

1. 3 receptors regulate ACTH release by AtT-20 cells. Eur. J. Pharmacol. 210 (1992) 31-35
2. 4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur. J. Pharmacol. 563 (2007) 240-244
3. 3 receptors in the regulation of gastric functions. J. Physiol. Pharmacol. 52 (2001) 539-553
4. Damaj B.B., Becerra C.B., Esber H.J., Wen Y., and Maghazachi A.A. Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J. Immunol. 179 (2007) 7907-7915
5. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. 26 (2005) 462-469
6. 4+ T cells. J. Immunol. 176 (2006) 7062-7070
7. Hofstra C.L., Desai P.J., Thurmond R.L., and Fung-Leung W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003) 1212-1221
8. Jablonowski J.A., Carruthers N.I., and Thurmond R.L. The histamine H4 receptor and potential therapeutic use for H4 ligands. Mini-Rev. Med. Chem. 4 (2004) 993-1000
9. 3 receptor drugs. Nat. Rev. Drug Discov. 4 (2005) 107-120
10. Levi R., and Smith N.C. Histamine H(3)-receptors: a new frontier in myocardial ischemia. J. Pharmacol. Exp. Ther. 292 (2000) 825-830
11. Ling P., Ngo K., Nguyen S., Thurmond R.L., Edwards J.P., Karlsson L., and Fung-Leung W.P. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 142 (2004) 161-171
12. Liu C., Wilson S.J., Kuei C., and Lovenberg T.W. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 299 (2001) 121-130
13. Nakamura T., Itadani H., Hidaka Y., Ohta M., and Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Comm. 279 (2000) 615-620
14. Oda T., Morikawa N., Saito Y., Masuho Y., and Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275 (2000) 36781-36786
15. Schwartz J.C., Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., Schunack W., Ganellin C.R., and Arrang J.M. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor. J. Neural. Transm., Suppl. 64 (2003) 1-16
16. Terzioglu N., van Rijn R.M., Bakker R.A., de Esch I.J., and Leurs R. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H4 receptor antagonists. Bioorg. Med. Chem. Lett. 14 (2004) 5251-5256
17. Thurmond R.L., Desai P.J., Dunford P.J., Fung-Leung W.P., Hofstra C.L., Jiang W., Nguyen S., Riley J.P., Sun S., Williams K.N., Edwards J.P., and Karlsson L. A potent and selective histamine H4 receptor rntagonist with anti-inflammatory properties. J. Exp. Pharmacol. Ther. 309 (2004) 404-413
18. van der Werf J.F., and Timmerman H. The histamine H3 receptor: a general presynaptic histaminergic regulatory system?. Trends Pharmacol. Sci. 10 (1989) 159-162
19. 3 receptors. Eur. J. Pharmacol. 267 (1994) 343-348
20. 4 receptor: a novel modulator of inflammatory and immune disorders. Pharmacol. Therapeut. 113 (2007) 594-606
21. Zhang M., Venable J.D., and Thurmond R.L. The histamine H4 receptor in autoimmune disease. Expert. Opin. Investig. Drugs. 15 (2006) 1443-1452
22. Zhu Y., Michalovich D., Wu H., Tan K.B., Dytko G.M., Mannan I.J., Boyce R., Alston J., Tierney L.A., Li X., Herrity N.C., Vawter L., Sarau H.M., Ames R.S., Davenport C.M., Hieble J.P., Wilson S., Bergsma D.J., and Fitzgerald L.R. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 59 (2001) 434-441